The NorthX Biologics Innovation Hub was supported by the Swedish government, through the national innovation agency Vinnova, towards enabling industrial scale production of Advanced Therapy Medicinal Products (ATMPs). This platform supports open collaboration with Biotech companies and other stakeholders including supporting process and analytical development, connections with financiers (public or private) and further production for clinical or commercial product. The Innovation Hub also serves an important role in competence and capacity development for industrial scale roles.
The report from the finalised establishment study can be found here; Rapport_kapacitet_tillverkning_vaccin
The hub is run in collaboration with NorthXBiologics and now welcomes customers Helping advance biologics and ATMP’s toward the clinic. (nxbio.com)
Contact: Luisa Lundin